Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
06/16/2011 | US20110144103 Pyrrole compounds that modulate hsp90 activity |
06/16/2011 | US20110144094 Heterocyclic tetracyclic tetrahydrofuran derivatives |
06/16/2011 | US20110144090 Compounds and methods of use thereof |
06/16/2011 | US20110144084 6 substituted 2- heterocyclylamino pyrazine compounds as chk-1 inhibitors |
06/16/2011 | US20110144080 Pyrazole derivatives as protein kinase modulators |
06/16/2011 | US20110144068 3,4-diarylpyrazoles as protein kinase inhibitors |
06/16/2011 | US20110144060 Substituted pyrazinone melanin concentrating hormone receptor-1 antagonists and methods |
06/16/2011 | US20110144056 Pyrazole derivatives useful as inhibitors of faah |
06/16/2011 | US20110143942 Pyrazolyl-Substituted Heterocycles and Their Use as Phytosanitary Products |
06/16/2011 | US20110143939 Quinoxalin-2-one derivatives, compositions which protect useful plants and comprise these derivatives, and processes for their preparation and their use |
06/16/2011 | US20110143445 Analysis of Amino Acids And Amine-Containing Compounds Using Tagging Reagents and LC-MS Workflow |
06/16/2011 | US20110143141 Photochromic compounds and compositions |
06/16/2011 | US20110142856 Compound containing basic group and use thereof |
06/16/2011 | US20110142798 Hepatitis c virus inhibitors |
06/16/2011 | US20110140092 Charge transport compositions and electronic devices made with such compositions |
06/16/2011 | US20110140056 Indeno-fused ring compounds |
06/16/2011 | US20110140043 Materials for organic electroluminescence device |
06/16/2011 | CA2783537A1 Benzamide compound |
06/16/2011 | CA2781888A1 Agents and methods for treating ischemic and other diseases |
06/16/2011 | CA2781839A1 Spiro indole - cyclopropane indolinones useful as ampk modulators |
06/16/2011 | CA2781685A1 Imidazolidinedione derivatives |
06/15/2011 | EP2332962A1 Cyclopenta[g]quinazoline compounds for use in the treatment of inflammatory or allergic conditions |
06/15/2011 | EP2332935A1 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
06/15/2011 | EP2332934A1 Chrystals including a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indole-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
06/15/2011 | EP2332924A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
06/15/2011 | EP2332912A1 Heteroarylaminosulfonylphenylderivates for use as sodium or calcium channel blockers in the treatment of pain |
06/15/2011 | EP2331530A2 Fused multicyclic compounds as protein kinase inhibitors |
06/15/2011 | EP2331529A2 Novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone and pharmaceutical compositions thereof |
06/15/2011 | EP2331528A2 Compounds for the treatment of inflammatory disorders |
06/15/2011 | EP2331527A1 Pyrazolyl-pyrimidine derivatives and their use as potassium channel modulators |
06/15/2011 | EP2331526A2 Pyrimidine derivatives as kinase inhibitors |
06/15/2011 | EP2331525A2 Halofuginone analogs for inhibition of trna synthetases and uses thereof |
06/15/2011 | EP2331524A1 Heterocyclically substituted anilinopyrimidines as fungicides |
06/15/2011 | EP2331511A1 Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections |
06/15/2011 | EP2331510A1 Novel substrates of o6-alkylguanine-dna alkyltransferase and mutants thereof |
06/15/2011 | EP2331506A1 Novel benzamides, production thereof, and use thereof as medicaments |
06/15/2011 | EP2331500A1 Pyrrolidine n-benzyl derivatives |
06/15/2011 | EP2331499A1 Cold menthol receptor antagonists |
06/15/2011 | EP2331095A1 Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
06/15/2011 | EP2203430B1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors |
06/15/2011 | EP2074086B1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
06/15/2011 | EP1937664B1 Hydrazide compound and pesticidal use of the same |
06/15/2011 | EP1937650B1 Heterocyclic compounds |
06/15/2011 | EP1784399B1 Pyrimidine derivatives |
06/15/2011 | EP1619185B1 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof |
06/15/2011 | EP1052254B1 Nitrogenous heterocyclic derivatives and medicine thereof |
06/15/2011 | EP0835110B2 Use of (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
06/15/2011 | CN1956964B Tetrahydro-indazole cannabinoid modulators |
06/15/2011 | CN1946714B Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors |
06/15/2011 | CN102099423A Azo compound, azo pigment, pigment dispersion, color composition, inkjet recording ink, color composition for color filter, color filter, and method for preparing color composition for color filter |
06/15/2011 | CN102099351A 3-heterocyclic substituted indole derivatives and methods of use thereof |
06/15/2011 | CN102099340A Heterocyclic compounds as factor IXA inhibitors |
06/15/2011 | CN102099339A Benzazepine derivatives and their use as hstamine h3 antagonists |
06/15/2011 | CN102099031A Substituted indolyl and indazolyl derivatives and uses thereof |
06/15/2011 | CN102093363A Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
06/15/2011 | CN102093341A Indole ring substituted pyrazole carboxylic acid endothelin receptor antagonist as well as preparation method and application thereof |
06/15/2011 | CN102093340A Preparation method and application of 2-methylindazole derivatives |
06/15/2011 | CN102093339A Preparation method and application of pyrimidine derivatives |
06/15/2011 | CN102093285A Cyclic amide derivatives, and their production and use as antithrombotic agents |
06/15/2011 | CN102093282A 肟酯光敏引发剂 Oxime ester photoinitiator |
06/15/2011 | CN101151259B Heteroaryl urea derivatives useful for inhibiting CHKI |
06/14/2011 | USRE42462 Carboxylic acid derivatives, their preparation and use |
06/14/2011 | US7960544 Useful indole compounds |
06/14/2011 | US7960417 Such as 1-(2,2-dimethylpropyl)-4-propyl-5-{4-[4-(1H-tetrazol-5-yl)phenoxy]butoxy}-1H-indole; neurological and psychiatric disorders |
06/14/2011 | US7960413 Pyrazole compounds |
06/14/2011 | US7960394 3,8-dimethyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]-4(3H)-quinazolinone; 6-chloro-3-methyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]pyrido[3,4-d]-pyrimidin-4(3H)-one; 2-[4-(1-cyclopentyl-4-piperidinyloxy)phenyl]-3-methylpyrido[2,3-d]-pyrimidin-4(3H)-one; treats metabolic, nervous system, vascular disorders |
06/14/2011 | US7960393 Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2 |
06/14/2011 | US7960377 Substituted pyridoxazines |
06/14/2011 | US7960372 Bivalent Smac mimetics and the uses thereof |
06/14/2011 | US7960182 Affinity adsorbents for Factor VIII and von Willebrand's Factor |
06/14/2011 | CA2643177C Multi-cyclic compounds for treating cancer |
06/14/2011 | CA2534921C Aminotriazole compounds useful as inhibitors of protein kinases |
06/14/2011 | CA2520586C Novel ido inhibitors and methods of use |
06/14/2011 | CA2495661C Inhibition of phosphoinositide 3-kinase beta |
06/14/2011 | CA2494962C Tyrosine kinase inhibitors |
06/14/2011 | CA2478232C Heterocyclic amide derivatives as cytokine inhibitors |
06/09/2011 | WO2011069053A1 Process for the preparation of pazopanip hcl and crystalline forms of pazopanib hcl |
06/09/2011 | WO2011068821A1 Benzimidazole inhibitors of leukotriene production |
06/09/2011 | WO2011068560A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
06/09/2011 | WO2011068187A1 Quinazoline derivatives |
06/09/2011 | WO2010143168A3 Compounds useful for treating cancer |
06/09/2011 | US20110137633 Anti-viral compounds and methods of identifying the same |
06/09/2011 | US20110137045 Benzimidazole derivatives |
06/09/2011 | US20110136881 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents |
06/09/2011 | US20110136875 Pyrrole Inhibitors of S-Nitrosoglutathione Reductase |
06/09/2011 | US20110136860 Compounds |
06/09/2011 | US20110136859 Compounds |
06/09/2011 | US20110136824 Urotensin ii receptor antagonists |
06/09/2011 | US20110136821 Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase Type 1 |
06/09/2011 | US20110136819 6-thioxopyridazine derivatives |
06/09/2011 | US20110136814 Diazepine and Diazocane Compounds As MC4 Agonists |
06/09/2011 | US20110136813 Wnt protein signalling inhibitors |
06/09/2011 | US20110136808 3',6-substituted indirubins and their biological applications |
06/09/2011 | US20110136807 Bicyclic compositions and methods for modulating a kinase cascade |
06/09/2011 | US20110136805 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for production of same |
06/09/2011 | US20110136802 Ship1 modulators and methods related thereto |
06/09/2011 | US20110136794 Novel pyrrole derivative having, as substituents, ureido group, aminocarbonly group and bicyclic group which may have substituent |
06/09/2011 | US20110136788 Therapeutic agent for irritable bowel syndrome |
06/09/2011 | US20110136766 Aurora kinase inhibitors |
06/09/2011 | US20110136762 Fungicidal pyridazines |